tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
US Market

Adaptimmune Therapeutics (ADAP) Technical Analysis

Compare
846 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 0.59, while Adaptimmune Therapeutics’s (ADAP) share price is $0.56, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 0.62, while Adaptimmune Therapeutics’s (ADAP) share price is $0.56, making it a Sell.

Adaptimmune Therapeutics (ADAP) Pivot Points

Feb 22, 2025, 04:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.53
0.55
0.56
0.58
0.60
0.61
0.63
Fibonacci
0.55
0.56
0.57
0.58
0.59
0.60
0.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAP) Moving Averages

Feb 22, 2025, 04:42 AM
Period
Simple
Exponential
MA5
0.58Sell
0.58Sell
MA10
0.59Sell
0.58Sell
MA20
0.59Sell
0.59Sell
MA50
0.60Sell
0.62Sell
MA100
0.69Sell
0.71Sell
MA200
0.90Sell
0.90Sell
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 0.58, while Adaptimmune Therapeutics’s (ADAP) share price is $0.56, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 0.71, while Adaptimmune Therapeutics’s (ADAP) share price is $0.56, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.56 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 0.60, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.56 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 0.69, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.56 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.90, creating a Sell signal.

Adaptimmune Therapeutics (ADAP) Technical Indicators

Feb 22, 2025, 04:42 AM
Name
Value
Implied Action
RSI (14)
45.27
Neutral
STOCH (9,6)
41.70
Neutral
STOCHRSI (14)
41.70
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
8.05
Buy
Williams %R
-57.75
Buy
CCI (14)
-117.77
Buy
ATR (14)
0.04
-
Ultimate Oscillator
59.72
Neutral
ROC
-4.92
Sell
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 45.27, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 8.05, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is -117.77, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is -4.92, creating a Sell signal.

FAQ

Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Strong Sell.
    What is ADAP’s RSI (14)?
    ADAP’s RSI (14) is 45.27, which suggests ADAP is a Neutral.
      What is ADAP’s MACD?
      ADAP’s MACD is >-0.01, which suggests ADAP is a Sell.
        What is ADAP’s 5-day moving average?
        ADAP’s 5-day moving average is 0.58, which suggests ADAP is a Sell.
          What is ADAP’s 20-day moving average?
          ADAP 20-day moving average is 0.59, which suggests ADAP is a Sell.
            What is ADAP’s 50-day moving average?
            ADAP’s 50-day moving average is 0.60, which suggests ADAP is a Sell.
              What is ADAP’s 200-day moving average?
              ADAP’s 200-day moving average is 0.90, which suggests ADAP is a Sell.
                What is ADAP’s Williams % R (14)?
                ADAP’s Williams % R (14) is -57.75, which suggests ADAP is a Buy.
                  What is ADAP’s CCI (14)?
                  ADAP’s CCI (14) is -117.77, which suggests ADAP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis